BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 36823409)

  • 21. Transforming Growth Factor-β1 Regulates Peroxisomal Genes/Proteins via Smad Signaling in Idiopathic Pulmonary Fibrosis Fibroblasts and Transgenic Mouse Models.
    Oruqaj G; Karnati S; Kotarkonda LK; Boateng E; Bartkuhn M; Zhang W; Ruppert C; Günther A; Bartholin L; Shi W; Baumgart-Vogt E
    Am J Pathol; 2023 Mar; 193(3):259-274. PubMed ID: 36521562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of AHNAK nucleoprotein 2 alleviates pulmonary fibrosis by downregulating the TGF-β1/Smad3 signaling pathway.
    Zhu D; Zhang Q; Li Q; Wang G; Guo Z
    J Gene Med; 2022 Sep; 24(9):e3442. PubMed ID: 35882062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
    Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
    J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
    Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L; Jiang D; Geng J; Dong R; Dai H
    Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
    Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
    Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
    Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway.
    Kim KH; Lee S; Lee H; Shin D; Min D; Kim M; Ryu B; Kim HW; Bae H
    Sci Rep; 2018 Nov; 8(1):16860. PubMed ID: 30443024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
    Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
    Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating rutin as a potential transforming growth factor-β type I receptor antagonist for the inhibition of bleomycin-induced lung fibrosis.
    Karunarathne WAHM; Lee KT; Choi YH; Kang CH; Lee MH; Kim SH; Kim GY
    Biofactors; 2024; 50(3):477-492. PubMed ID: 38006284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition.
    Zhou Y; He Z; Gao Y; Zheng R; Zhang X; Zhao L; Tan M
    Front Pharmacol; 2016; 7():430. PubMed ID: 27895584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression and protective effect of chemerin in idiopathic pulmonary fibrosis].
    Shen CY; Li GR; Wei D; Wang W; Yang XS; Jiang C; Sheng YT; Yang ZK; Nie XW; Chen JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Jul; 46(7):688-696. PubMed ID: 37402659
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitory Effects of 3-Cyclopropylmethoxy-4-(difluoromethoxy) Benzoic Acid on TGF-β1-Induced Epithelial-Mesenchymal Transformation of In Vitro and Bleomycin-Induced Pulmonary Fibrosis In Vivo.
    Sun T; Li H; Zhang Y; Xiong G; Liang Y; Lu F; Zheng R; Zou Q; Hao J
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bufotalin attenuates pulmonary fibrosis via inhibiting Akt/GSK-3β/β-catenin signaling pathway.
    Yin JZ; Li ZQ; Zhang XD; Wan ZJ; Qin HR; Yao LH; Li BL; Gao F; Yang YY
    Eur J Pharmacol; 2024 Feb; 964():176293. PubMed ID: 38158113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dehydrozingerone alleviates pulmonary fibrosis via inhibition of inflammation and epithelial-mesenchymal transition by regulating the Wnt/β-catenin pathway.
    Shaikh TB; Kuncha M; Andugulapati SB; Sistla R
    Eur J Pharmacol; 2023 Aug; 953():175820. PubMed ID: 37245857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diosgenin inhibits TGF-β1/Smad signaling and regulates epithelial mesenchymal transition in experimental pulmonary fibrosis.
    Dinesh Babu V; Suresh Kumar A; Sudhandiran G
    Drug Chem Toxicol; 2022 May; 45(3):1264-1275. PubMed ID: 32924642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis.
    Wan X; Tian X; Du J; Lu Y; Xiao Y
    Respir Res; 2020 Nov; 21(1):290. PubMed ID: 33138822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
    Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
    Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
    Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
    Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.